by JULIE BISHOP
This post has been written in response to an article posted on Mamamia yesterday by Health Minister Tanya Plibersek, you can read that HERE.
It is deeply troubling that Health Minister Tanya Plibersek has sought to exploit the very personal, emotional and often traumatic issue of abortion to launch a selective and misleading political attack on Opposition Leader Tony Abbott.
For the record, I am pro-choice and voted in support of the 2006 legislation to remove the effective Ministerial veto over approval of the abortion drug RU486.
Ms Plibersek makes the false assertion that as Health Minister Tony Abbott misrepresented advice from the Chief Medical Officer at the time. Not only is it untrue, Tony in fact publicly released that advice in 2005. Ms Plibersek also asserts that Tony Abbot sought to retain a veto over RU-486 “so he could prevent it being imported into Australia”.
Yet the readily-available official public record shows that assertion is also false.
It has been Tony Abbott’s consistent position that the Therapeutic Goods Administration in Australia has sole responsibility for the registration of RU-486 and he has confirmed that he will not change that arrangement in government.
Ms Plibersek well knows this to be the case, for shortly after the Parliamentary debate on RU486, her NSW Labor colleague and MP John Murphy asked Tony Abbott in the Parliament in March 2006 about “the article published on the Catholic News Agency website on 20 March 2006 titled ‘Two more women die after taking abortion drug RU-486’ which reported that the United States Food and Drug Administration (FDA) has not pulled Mifeprex, the drug known as RU-486, despite the fact that the FDA has reported that two more women died after taking the drug, that there have been seven reported deaths in the USA and 12 deaths worldwide of women who took RU-486 and that the FDA has received more than 800 reports of complications caused by the drug RU-486.” Mr Murphy also asked what actions Minister Abbott was taking to “prevent the sale of RU-486”.